# Anti-Kpa antibody: Getting to know a strange and dangerous specificity

## TL;DR

Anti-Kpa is a rare but dangerous antibody targeting a red blood cell antigen, which can cause severe transfusion reactions and fetal anemia.

## Contribution

This paper highlights the clinical significance and rare occurrence of Anti-Kpa antibodies in transfusion and pregnancy contexts.

## Key findings

- Anti-Kpa antibodies are rare but can cause hemolytic reactions and fetal anemia.
- They are less common than other Kell system antibodies like anti-K.
- Detection is challenging in routine pre-transfusion testing.

## Abstract

Anti-Kpa is an irregular antibody of clinical significance directed against the red blood cell antigen Kpa of the Kell system. It is rare in the general population and, therefore, uncommon as a cause of transfusion or hemolytic complications. It has been documented in isolated cases, mainly in the context of alloimmunization after transfusion exposure or during pregnancy; its incidence in clinical practice is limited and can be difficult to detect in routine pre-transfusion testing, which could lead to failure to identify the antibody prior to transfusion.

The production of Anti-Kpa antibodies is less common than antibodies against other Kell system antigens, such as anti-K. However, when generated, these antibodies can mediate hemolytic reactions in patients receiving incompatible blood and can cause hemolytic disease in the fetus since in addition to immune destruction of red blood cells, Kell system antibodies such as Anti-Kpa can cause suppression of fetal erythropoiesis, resulting in severe anemia.